RecruitingNot Applicable

REGistry of Long-term AnTithrombotic TherApy-1

Russia2,000 participantsStarted 2015-01-15

Plain-language summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging Exclusion Criteria: * Subjects who are unwilling or unable to provide informed consent. * Acute coronary syndrome within 12 months before inclusion * Severe chronic heart failure (NYHA IV) * Stroke within 6 months before inclusion * Severe liver or muscle disease * Severe kidney disease / renal failure with creatinine \> 3 mg/dl * Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -

What they're measuring

composite of major adverse cardiovascular events (MACE)

Timeframe: inclusion up to 5 years

composite of any bleeding events

Timeframe: inclusion up to 5 years

Trial details

NCT IDNCT04347200

SponsorNational Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-12-31

Contact for this trial

Andrey Komarov, PhD

+79161813257 andrkomarov@mail.ru

View on ClinicalTrials.gov More Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) trials